Keystone Financial Planning’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$266K Hold
7,014
– – 0.07% 38
2026
Q2
$336K Buy
+7,014
New +$301K 0.09% 37
2024
Q3
– Sell
-1,425
Closed -$203K – 48
2024
Q2
$203K Buy
+1,425
New +$189K 0.07% 49
2014
Q1
– Sell
-1,220
Closed -$23K – 76
2013
Q4
$23K Buy
+1,220
New +$21.3K 0.02% 71

Other funds holding NVO

Keystone Financial Planning's NVO Position: Q3 2026 in Review

Keystone Financial Planning held its Novo Nordisk (NVO) position steady in Q3 2026 at 7,014 shares worth $266K. The position accounts for 0.07% of the portfolio, ranked #38.

Keystone Financial Planning first reported a position in NVO in Q4 2013 and has held it in 4 quarters since. The position peaked at $336K in Q2 2026. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Keystone Financial Planning held 7,014 shares of Novo Nordisk worth $266K as of Q3 2026.
  • Keystone Financial Planning left its Novo Nordisk share count unchanged in Q3 2026.
  • Novo Nordisk made up 0.07% of Keystone Financial Planning's portfolio in Q3 2026, its #38 holding.
  • Keystone Financial Planning first reported a position in Novo Nordisk in Q4 2013 and has held it in 4 quarters since.
  • Keystone Financial Planning's Novo Nordisk position peaked at $336K in Q2 2026.
  • 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Keystone Financial Planning's 13F filing for Q3 2026, filed 8 Oct 2026.